GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $140.80 $156.84 Wednesday, 17th Apr 2024 ASND stock ended at $142.17. This is 0.473% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 2.45% from a day low at $140.80 to a day high of $144.25.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2023-12-28 $126.86 $128.98 $125.13 $127.36 414 998
2023-12-27 $127.80 $129.43 $126.23 $127.10 323 804
2023-12-26 $125.22 $127.30 $123.66 $127.12 423 828
2023-12-22 $122.04 $126.00 $121.40 $124.55 568 790
2023-12-21 $122.01 $123.31 $119.82 $121.80 196 785
2023-12-20 $125.35 $125.35 $120.93 $121.16 513 062
2023-12-19 $122.09 $123.67 $119.72 $123.23 446 986
2023-12-18 $121.74 $122.99 $118.25 $120.89 1 027 544
2023-12-15 $121.17 $123.00 $120.03 $120.97 1 025 713
2023-12-14 $117.69 $122.11 $117.34 $120.11 1 388 586
2023-12-13 $110.24 $118.23 $110.02 $117.69 1 140 095
2023-12-12 $107.70 $111.20 $105.77 $110.19 853 190
2023-12-11 $107.81 $108.98 $101.43 $108.58 1 373 345
2023-12-08 $107.67 $111.41 $106.49 $107.69 1 067 682
2023-12-07 $106.75 $109.48 $105.57 $108.80 855 074
2023-12-06 $106.64 $108.54 $105.05 $106.50 636 264
2023-12-05 $104.49 $106.71 $103.48 $105.62 519 671
2023-12-04 $104.39 $106.65 $103.19 $105.04 262 480
2023-12-01 $101.00 $104.05 $99.64 $104.05 337 153
2023-11-30 $97.87 $101.96 $97.87 $100.43 399 502
2023-11-29 $91.20 $98.41 $91.20 $97.07 562 468
2023-11-28 $91.43 $91.77 $90.27 $90.62 216 862
2023-11-27 $91.41 $92.70 $90.88 $91.41 208 156
2023-11-24 $93.22 $94.25 $90.56 $92.24 173 500
2023-11-22 $93.86 $94.93 $92.40 $93.00 150 789
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT